Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients.
about
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesFree serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosisLongitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients.Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults.Targeting iron metabolism in drug discovery and deliveryPathogenic implications of distinct patterns of iron and zinc in chronic MS lesionsPathogenic implications of iron accumulation in multiple sclerosis.Iron and mechanisms of neurotoxicityPrediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.Iron and neurodegeneration in multiple sclerosis.Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.The Brain Proteome of the Ubiquitin Ligase Peli1 Knock-Out Mouse during Experimental Autoimmune EncephalomyelitisSignificant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model.Restless legs syndrome as the initial presentation of multiple sclerosis.Restless legs syndrome presenting as an acute exacerbation of multiple sclerosis.Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis.Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.Iron and volume in the deep gray matter: association with cognitive impairment in multiple sclerosis.Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imagingHeavy Metals and Multiple Sclerosis in Sardinian Population (Italy)
P2860
Q28388335-F8E16C74-259F-429F-94E0-86476C919FC6Q28586716-ED1FC130-2891-4404-92DC-CA67E1FE3454Q31166761-644AAD28-8F3C-4051-9A60-694DD068C88AQ33394453-646541CF-4F94-4F40-B11C-D7918DE93B36Q33587212-591AE580-2B54-4D15-A45D-AFF651AB2CFAQ33757232-BECA2DAE-6126-4D9C-AB79-A41498B5DE0BQ33841090-C4F41C62-EC2A-4670-9270-587596C5E989Q34049616-DA8C686A-2AB1-490D-914C-DF11F1463597Q34460764-62241F80-B7AE-4869-BC7E-27DF731A3B66Q34537576-3E13E2A5-702F-4083-9BD8-C6786642E7DCQ34835462-686CD3ED-C0EA-460E-8170-E9D6EA4F1623Q35379973-AD89AB96-1E80-4EBE-B929-4F0D55613DFAQ36727013-CBF4EBEF-197C-49B8-8878-F4214C66F172Q37333860-2E6BC38C-589F-4401-8139-5F2A5C33F0C7Q37390184-33A12C90-23F1-4340-A7F4-52C16086141CQ37433129-597B9C3D-929E-4908-8A46-ED65FA60E4B4Q38802029-D9C7D892-AA0B-47A7-9A94-C431CC01C95CQ44554584-57B8B3A2-B263-4C9D-AEDC-ACB2AD8C5511Q46301002-BC88434A-D880-4397-9531-FAAB85BFD815Q46925588-6290C77B-9930-4B34-8994-010E42507DFEQ48553203-866A89A0-F34B-4B25-B533-AE7EB621E6D0Q48706282-83F753BD-817B-4C78-B74A-16ED05C91119Q48944544-281C426E-A54E-46DE-A38F-C7D8FADAA612Q56975741-0CD47268-6E2E-4D0D-B8AA-0626825587C5Q58127457-5C9AF761-305D-412F-B03C-4C8442CE4CDB
P2860
Ferritin, transferrin and iron concentrations in the cerebrospinal fluid of multiple sclerosis patients.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@ast
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@en
type
label
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@ast
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@en
prefLabel
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@ast
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@en
P2093
P1433
P1476
Ferritin, transferrin and iron ...... f multiple sclerosis patients.
@en
P2093
P304
P356
10.1016/S0006-8993(98)01360-2
P407
P577
1999-03-01T00:00:00Z